• Today May 13
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea.
April 25, 10:00
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services (“PCI”) - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - is acquiring an entire equity stake in Ajinomoto A
April 25, 09:36
DNIB.com Reports Internet Has 368.4 Million Domain Name Registrations at the End of the First Quarter of 2025
VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarter
Rimini Street Appoints Joe Locandro as EVP and Chief Information Officer to Lead Global IT Strategy
April 25, 09:28
Rimini Street Appoints Joe Locandro as EVP and Chief Information Officer to Lead Global IT Strategy
Rimini Street, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.riministreet.com%2F%3Futm_source%3Dpressrelease%26utm_medium%3DReferral%26utm_campaign%3DJoeLocandroAnnouncem
April 24, 16:10
Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 m
Hinda Gharbi, CEO at Bureau Veritas
April 24, 15:39
Bureau Veritas: A Robust First Quarter and an Unchanged 2025 Outlook; Increased Returns to Shareholders with a EUR 200m Share Buyback Program
Bureau Veritas (BOURSE:BVI): Q1 2025 Key figures[1] › Revenue of EUR 1,558.7 million, up 8.3% year-on-year and up 7.3% organically › Strong organic growth from Industry at +14.3%, Marine & Offs
April 24, 14:15
Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025. · Net sales: Achieved 1,129 million USD in net sales, u
Azizi Milan, the new fashion capital of the Middle East (Photo: AETOSWire)
April 24, 14:05
Azizi Developments Unveils Azizi Milan, the New Fashion Capital of the Middle East
Azizi Developments, a leading private developer in the UAE, has unveiled Azizi Milan, a landmark master-planned community, guided by the principles of sustainability, nature, and the cultured refineme
Charlene Chen, PhD, Deputy General Manager & Head of the Center of Toxicology and Preclinical Scienc
April 24, 10:30
QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis
QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models p
Fab utilization rates (%)
April 24, 09:55
Omdia: Display Makers Cut Capacity Utilization During Uncertainty Over Display Application Tariffs
According to the latest report from Omdia’s Large Area Display Production Strategy Tracker (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fomdia.tech.informa.com%2Fadvance-your-busi
A special exhibition at The smarter E Europe is dedicated to bidirectional charging. ©Solar Promotio
April 23, 16:10
The Smarter E Europe: Launch of Special Exhibit on Bidirectional Charging - the Energy Transition Gains Traction
Electricity from renewable sources has become the new normal - in Germany alone, around 60 percent of net electricity generation came from renewables in 2024. But the growing volume of green power is
April 23, 15:15
Venture Global Announces Closing of $2,500,000,000 Senior Secured Notes by Venture Global Plaquemines LNG, LLC
Venture Global Inc. (“Venture Global”) announced today that its subsidiary, Venture Global Plaquemines LNG, LLC (“VGPL”) has closed an offering of $2,500,000,000 aggregate principal amount of senior s
April 23, 15:00
Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
Invivoscribe is proud to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM), LLC has received approval from the New York State Department of Health
Aster Guardians Global Nursing Award 2025 - Grand Jury (Photo: AETOSWire)
April 23, 14:35
Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai
Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in
April 23, 14:05
MSCI and Moody's to Launch Independent Risk Assessments for Private Credit Investments
MSCI Inc. (NYSE:MSCI) and Moody’s Corporation (NYSE:MCO) will jointly create a first-of-its-kind solution to provide independent risk assessments for private credit investments at scale. As the pri
Sports company PUMA has achieved its goal of making 9 out of 10 products from recycled or certified
April 23, 11:55
PUMA Reaches Goal of Making 9 Out of 10 Products With Recycled or Certified Materials
Sports company PUMA has achieved its goal of making 9 out of 10 products from recycled or certified materials in 2024 and made further progress in its focus areas circularity, climate and human rights
The agreement to purchase GSDMIA‘s assets boosts AIT’s specialized service expertise for the cosmeti
April 23, 11:15
AIT Worldwide Logistics acquires Miami-based forwarder, GSDMIA, Inc.
Global supply chain solutions leader AIT Worldwide Logistics has finalized an agreement to purchase the assets of GSDMIA, Inc. (“GSDMIA”), an international freight forwarder based in Miami. Accordi
Brian Franz Appointed Chief Technology, Data & Analytics Officer of The Estée Lauder Companies
April 23, 09:30
Brian Franz Appointed Chief Technology, Data & Analytics Officer of The Estée Lauder Companies
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Brian Franz as Chief Technology, Data & Analytics Officer, effective April 21, 2025. Mr. Franz will report to President an
The Arthur D. Little 2025 CEO Insights Study interviewed 309 global CEOs leading companies with a tu
April 23, 08:42
Report from Arthur D. Little Finds Global CEOs Ready to Embrace Geopolitical and Technology Changes
Despite geopolitical upheavals and the current market turmoil, CEOs of the world’s largest companies have already invested heavily to adapt to the changes created by such global shifts, and the introd
April 22, 16:38
A new weapon in the global fight against malaria
Malaria is one of the world’s most deadly diseases, and it is becoming more pervasive - despite decades of effort and some successes on the path to eradicating it. According to the World Health Organi
Belkin achieves carbon neutrality in scope 1 and scope 2 emissions
April 22, 15:00
Belkin Achieves Carbon Neutrality in Scope 1 and Scope 2 Emissions
Belkin (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.belkin.com%2Fhomepage.html&esheet=54240260&newsitemid=20250421326773&lan=en-US&anchor=Belkin&index=1&md5=2bc6481d9061816cb
April 22, 14:30
Laserfiche Demonstrates AI-Powered ECM at GITEX ASIA
Laserfiche (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.laserfiche.com%2F%3Futm_source%3Dbusinesswire%26utm_medium%3Dpr&esheet=54240304&newsitemid=20250420622727&lan=en-US&an
April 22, 10:35
Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug d
April 22, 10:20
Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1
Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in patients with high-risk Bacillus Calmette-Gu
LUX My Like First
April 20, 12:10
LUX Has Turned Hitting the Like Button Into a Power Move in New Campaign. And We Love How Unapologetic It Is!
The Like button was born on Feb 9, 2009. Ever since, it’s been running the show. With many using likes and comments to pass judgements on women and expressions of beauty, this has led women to quietly
Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, Preside
April 20, 11:45
Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development
Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Re
25 per page50 per page75 per page100 per page